ConductScience.org, home

Paper25979640

Forecasting carbapenem resistance from antimicrobial consumption surveillance: Lessons learnt from an OXA-48-producing Klebsiella pneumoniae outbreak in a West London renal unit.

Gharbi M and 6 others. Int J Antimicrob Agents, 2015. Cited by 43 papers, by iCite.

Cite this record

ConductScience Library. Forecasting carbapenem resistance from antimicrobial consumption surveillance: Lessons learnt from an OXA-48-producing Klebsiella pneumoniae outbreak in a West London renal unit. Papers, record 25979640. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/25979640

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Forecasting carbapenem resistance from antimicrobial consumption surveillance: Lessons learnt from an OXA-48-producing Klebsiella pneumoniae outbreak in a West London renal unit.
PubMed
Journal
Int J Antimicrob Agents
PubMed
Year
2015
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
43
iCite
Relative citation ratio, by iCite
1.94
iCite
Revised in PubMed
2025-05-29
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Gharbi MM
2Moore LSL S P
3Gilchrist MM
4Thomas CPC P
5Bamford KK
6Brannigan ETE T
7Holmes AHA H

Source PubMed

Download CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anti-Bacterial AgentsMajor topic
Disease OutbreaksMajor topic
Drug UtilizationMajor topic
Klebsiella InfectionsMajor topic
Klebsiella pneumoniaeMajor topic
ThienamycinsMajor topic
beta-LactamasesMajor topic
Epidemiological Monitoring
Forecasting
Hospitals
Humans
Incidence
London
Meropenem
Models, Statistical
Retrospective Studies
beta-Lactam Resistance

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
G0800777Medical Research CouncilUnited KingdomPubMed

Source PubMed

Download CSV of grants

References21

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
19710666Antibiotic-selective environments.Clin Infect Dis1998https://conductscience.org/library/papers/9710666PubMed
223489756Annual Report of the Chief Medical Officer: infection and the rise of antimicrobial resistance.Lancet2013https://conductscience.org/library/papers/23489756PubMed
312174032Segmented regression analysis of interrupted time series studies in medication use research.J Clin Pharm Ther2002https://conductscience.org/library/papers/12174032PubMed
423633313Interventions to improve antibiotic prescribing practices for hospital inpatients.Cochrane Database Syst Rev2013https://conductscience.org/library/papers/23633313PubMed
517376385The ORION statement: guidelines for transparent reporting of outbreak reports and intervention studies of nosocomial infection.Lancet Infect Dis2007https://conductscience.org/library/papers/17376385PubMed
623750724Increasing prevalence of carbapenem-resistant Enterobacteriaceae and strategies to avert a looming crisis.Expert Rev Anti Infect Ther2013https://conductscience.org/library/papers/23750724PubMed
715095767Interrupted time series designs in health technology assessment: lessons from two systematic reviews of behavior change strategies.Int J Technol Assess Health Care2003https://conductscience.org/library/papers/15095767PubMed
810717497Modelling and forecasting antimicrobial resistance and its dynamic relationship to antimicrobial use: a time series analysis.Int J Antimicrob Agents2000https://conductscience.org/library/papers/10717497PubMed
924162744Implementing a strategy for monitoring inpatient antimicrobial use among hospitals in the United States.Clin Infect Dis2014https://conductscience.org/library/papers/24162744PubMed
1022282479Pharmacokinetics and pharmacodynamics of piperacillin-tazobactam in 42 patients treated with concomitant CRRT.Clin J Am Soc Nephrol2012https://conductscience.org/library/papers/22282479PubMed
118589129The relationship between antecedent antibiotic use and resistance to extended-spectrum cephalosporins in group I beta-lactamase-producing organisms.Clin Infect Dis1995https://conductscience.org/library/papers/8589129PubMed
1221649882Recommended β-lactam regimens are inadequate in septic patients treated with continuous renal replacement therapy.Crit Care2011https://conductscience.org/library/papers/21649882PubMed
131399923Ciprofloxacin and Clostridium difficile-associated diarrhoea.J Antimicrob Chemother1992https://conductscience.org/library/papers/1399923PubMed
1421303394Multiresistant Gram-negative bacteria: the role of high-risk clones in the dissemination of antibiotic resistance.FEMS Microbiol Rev2011https://conductscience.org/library/papers/21303394PubMed
152745711The science of public health surveillance.J Public Health Policy1989https://conductscience.org/library/papers/2745711PubMed
1625118270
Homogeneity of antimicrobial policy, yet heterogeneity of antimicrobial resistance: antimicrobial non-susceptibility among 108,717 clinical isolates from primary, secondary and tertiary care patients in London.
J Antimicrob Chemother2014https://conductscience.org/library/papers/25118270PubMed
1723276500
Approaching zero: temporal effects of a restrictive antibiotic policy on hospital-acquired Clostridium difficile, extended-spectrum β-lactamase-producing coliforms and meticillin-resistant Staphylococcus aureus.
Int J Antimicrob Agents2013https://conductscience.org/library/papers/23276500PubMed
1823876330Evaluation of a national microbiological surveillance system to inform automated outbreak detection.J Infect2013https://conductscience.org/library/papers/23876330PubMed
1924207018Early (2008-2010) hospital outbreak of Klebsiella pneumoniae producing OXA-48 carbapenemase in the UK.Int J Antimicrob Agents2013https://conductscience.org/library/papers/24207018PubMed
201955267The use of transfer function models, intervention analysis and related time series methods in epidemiology.Int J Epidemiol1991https://conductscience.org/library/papers/1955267PubMed

See all 21 referencesDownload CSV of references

Cited by22

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 43 citations.

PMIDTitleJournalYearIn PapersSource
41965560
Dynamic regression forecasting of carbapenem-resistant Klebsiella spp. based on carbapenem consumption with observed data from 2020 to 2023 and projections up to 2029 in a tertiary hospital in Alexandria, Egypt.
BMC Infect Dis2026https://conductscience.org/library/papers/41965560PubMed
41148713
Correlation Between Antimicrobial Consumption and Resistance in Klebsiella pneumoniae During the COVID-19 Pandemic Using Dynamic Regression Models: A Quasi-Experimental Epidemiological Time-Series Study.
Antibiotics (Basel)2025https://conductscience.org/library/papers/41148713PubMed
40724573Which Classes of Antibiotics Are Associated with the Acquisition of Carbapenemase-Producing Enterobacterales?Life (Basel)2025https://conductscience.org/library/papers/40724573PubMed
39754681Long-term forecast for antibacterial drug consumption in Germany using ARIMA models.Naunyn Schmiedebergs Arch Pharmacol2025https://conductscience.org/library/papers/39754681PubMed
39487661Ceftazidime with avibactam for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment model.Health Technol Assess2024https://conductscience.org/library/papers/39487661PubMed
38938145Cefiderocol for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment model.Health Technol Assess2024https://conductscience.org/library/papers/38938145PubMed
37697357Usefulness of dynamic regression time series models for studying the relationship between antimicrobial consumption and bacterial antimicrobial resistance in hospitals: a systematic review.Antimicrob Resist Infect Control2023https://conductscience.org/library/papers/37697357PubMed
36694849Systematic review of time lag between antibiotic use and rise of resistant pathogens among hospitalized adults in Europe.JAC Antimicrob Resist2023https://conductscience.org/library/papers/36694849PubMed
36422214An Overview on Phenotypic and Genotypic Characterisation of Carbapenem-Resistant Enterobacterales.Medicina (Kaunas)2022https://conductscience.org/library/papers/36422214PubMed
35856662OXA-48-Like β-Lactamases: Global Epidemiology, Treatment Options, and Development Pipeline.Antimicrob Agents Chemother2022https://conductscience.org/library/papers/35856662PubMed
34948564Extended-Spectrum Beta-Lactamase-Producing and Carbapenem-Resistant Enterobacterales in Companion and Animal-Assisted Interventions Dogs.Int J Environ Res Public Health2021https://conductscience.org/library/papers/34948564PubMed
33299948
Implementation of an infection control program with emphasis on cohorting to patients with carbapenemase-producing Enterobacteriaceae. The experience of 2 years in a tertiary teaching hospital in northern Portugal.
Porto Biomed J2020https://conductscience.org/library/papers/33299948PubMed
31988746Infection control and risk factors for acquisition of carbapenemase-producing enterobacteriaceae. A 5 year (2011-2016) case-control study.Antimicrob Resist Infect Control2020https://conductscience.org/library/papers/31988746PubMed
31771707Antibiotic consumption in Belgian acute care hospitals: analysis of the surveillance methodology, consumption evolution 2003 to 2016 and future perspectives.Euro Surveill2019https://conductscience.org/library/papers/31771707PubMed
31722889The Global Ascendency of OXA-48-Type Carbapenemases.Clin Microbiol Rev2019https://conductscience.org/library/papers/31722889PubMed
31276536Quantifying uncertainty about future antimicrobial resistance: Comparing structured expert judgment and statistical forecasting methods.PLoS One2019https://conductscience.org/library/papers/31276536PubMed
30568986Semi-Automated Visualization and ANalysis of Trends: A "SAVANT" for Facilitating Antimicrobial Stewardship Using Antistaphylococcal Resistance and Consumption as a Prototype.Open Forum Infect Dis2018https://conductscience.org/library/papers/30568986PubMed
29739906Ceftazidime Is the Key Diversification and Selection Driver of VIM-Type Carbapenemases.mBio2018https://conductscience.org/library/papers/29739906PubMed
29458443Epidemiology and control measures of an OXA-48-producing Enterobacteriaceae hospital-wide oligoclonal outbreak.Epidemiol Infect2018https://conductscience.org/library/papers/29458443PubMed
29177610Findings from an outbreak of carbapenem-resistant Klebsiella pneumoniae emphasize the role of antibiotic treatment for cross transmission.Infection2018https://conductscience.org/library/papers/29177610PubMed

See all 22 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/25979640

GET https://conductscience.org/api/papers/v1/25979640/references?page=2